Pharmacological Inhibition of Complement C5a-C5a1 Receptor Signalling Ameliorates Disease Pathology in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
British Journal of Pharmacology - United States
doi 10.1111/bph.13730
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 3, 2017
Authors
Publisher
Wiley